Name: Receivables Turnover

Definition: Receivables turnover tells you how quickly the company collects payments from customers after making sales on credit. A high turnover means customers pay on time and cash flows smoothly. Slow turnover suggests delayed collections, which can create cash shortages and financing stress.

Interpretation:
• In '2021', ONMD's receivables turnover was 11.90, showing efficiency in collecting outstanding receivables. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2021' stood at 3.19.
• In '2022', ONMD's receivables turnover was 20.82, showing efficiency in collecting outstanding receivables. The increase since '2021' reflects strengthening financial performance. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2022' stood at 3.95. Industry average increased by 0.76 compared to previous year.
• In '2023', ONMD's receivables turnover was 11.94, showing efficiency in collecting outstanding receivables. The decline from '2022' may indicate some operational or financial challenges. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2023' stood at 4.44. Industry average increased by 0.48 compared to previous year.
• In '2024', ONMD's receivables turnover was 3.52, showing efficiency in collecting outstanding receivables. The decline from '2023' may indicate some operational or financial challenges. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2024' stood at 5.65. Industry average increased by 1.21 compared to previous year.
Overall, ONMD's receivables turnover has been volatile but showed a downward trend over the past 4 years.

Formula: Receivables Turnover = Net Credit Sales / Average Accounts Receivable

Good Range: Ranges 5 to 15 depending on credit terms.